Genomic Vision S.A. buy melinda
Start price
17.03.16
/
50%
€7.46
Target price
23.03.16
€8.50
Performance (%)
14.75%
End price
23.03.16
€8.56
Summary
This prediction ended on 23.03.16 with a price of €8.56. The BUY prediction by melinda finished with a performance of 14.75%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Genomic Vision S.A. | - | - | - | - |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
According to melinda what are the pros and cons of Genomic Vision S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Genomic Vision S.A. diskutieren
technologie
Genomic Vision : obtient la certification qualité NF EN ISO 13485:2012
(Zielkurs erreicht)
Stopped prediction by melinda for Genomic Vision S.A.
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.30
12.11.21
12.11.21
€0.50
12.11.22
12.11.22
-78.55%
13.11.22
13.11.22
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.52
29.09.21
29.09.21
€0.75
29.09.22
29.09.22
-20.66%
09.10.21
09.10.21
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.54
13.02.20
13.02.20
-
04.11.21
04.11.21
-2.46%
29.09.21
29.09.21
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€8.60
23.03.16
23.03.16
€20.00
26.09.16
26.09.16
-15.12%
26.09.16
26.09.16
Could be worthwhile Investment >10% per year